Conversation

they are pumping $BNGO again
Quote Tweet
$BNGO Oppenheimer says that Bionano Genomics (NASDAQ:BNGO) is a buy due to strong 2021 sales of its Saphyr System for genome imaging. The firm has a $14 price target on shares (332% upside based on Thursday's close). seekingalpha.com/news/3783451-b
Show this thread